Studies have found that these subcohorts demonstrate metabolic risk rates substantially higher than in the general public, and have attributed this observational disparity to multiple factors, including patients reduced physical activity, diminished baseline motivation, and the metabolic side effects of essential antipsychotic treatments like olanzapine and clozapine
Patient Selection & Clinical Decision-Making When orforglipron reaches the market, clinicians will face a new decision matrix: which GLP-1 therapy, among a growing array of options, best fits each individual patient
Adding B12 directly to the injection bypasses the digestive system entirely
It will be quite negative for our patients because data shows people typically regain weight after stopping the drugs, said Diana Thiara, medical director of the University of California-San Francisco Weight Management Program
What Precautions and Warnings Should You Know About Acetyl-L-Carnitine